In summary, the high-quality and large 3D chromatin data along with many ChIP-seq and RNA-seq data provided a comprehensive resource for understanding how estrogen exposure drives genome-wide 3D chromatin reorganization in ERα-positive breast cancer cells as well as how their alterations occur in hormone resistant cells. The gene discussed is ESR1; the disease is breast cancer.